Cytochrome P450 4A Isoform Inhibitory Profile of N-Hydroxy-N'-(4-butyl-2-methylphenyl)-formamidine (HET0016), a Selective Inhibitor of 20-HETE Synthesis(Pharmacology)
スポンサーリンク
概要
- 論文の詳細を見る
We examined the effect of N-hydroxy-N'-(4-butyl-2-methylphenyl)-formamidine)(HET0016), an inhibitor of 20-hydroxy-5,8,11,14-eicosatetraenoic acid (20-HETE) synthesis on the ω-hydroxylation and epoxidation of arachidonic acid (AA) catalyzed by recombinant cytochrome P450 4A1 (CYP4A1), CYP4A2 and CYP4A3, and characterized the enzyme inhibitory profile of HET0016. The IC_<50> values of HET0016 for recombinant CYP4A1-, CYP4A2- and CYP4A3-catalyzed 20-HETE synthesis averaged 17.7nM, 12.1nM and 20.6nM, respectively. The IC_<50> value for production of 11,12-epoxy-5,8,14-eicosatrienoic acid (11,12-EET) by CYP4A2 and 4A3 averaged 12.7nM and 22.0nM, respectively. The IC_<50> value for CYP2C11 activity was 611nM which was much greater than that for CYP4As. The initial velocity study showed the K_i value of HET0016 for CYP4A1 was 19.5nM and a plot of V_<max> versus amount of recombinant CYP4A1 added shows HET0016 is an irreversible non-competitive inhibitor. These results indicate that HET0016 is a selective, non-competitive and irreversible inhibitor of CYP4A.
- 公益社団法人日本薬学会の論文
- 2005-09-01
著者
-
SEKI Takayuki
Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd.
-
MIYATA Noriyuki
Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd.
-
Seki Takayuki
Medicinal Pharmacology Laboratory Medicinal Research Laboratories Taisho Pharmaceutical Co. Ltd.
-
Laniado Schwartzman
Department Of Pharmacology New York Medical College
-
WANG Mong
Department of Physiology, Medical College of Georgia
-
Miyata Noriyuki
Medicinal Pharmacology Laboratory Medicinal Research Laboratories Taisho Pharmaceutical Co. Ltd.
-
Wang Mong
Department Of Physiology Medical College Of Georgia
-
Wang Mong-Heng
Department of Physiology, Medical College of Georgia
関連論文
- Increased Excretion of Urinary 20-HETE in Rats With Cyclosporine-Induced Nephrotoxicity
- Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system
- Cytochrome P450 4A Isoform Inhibitory Profile of N-Hydroxy-N'-(4-butyl-2-methylphenyl)-formamidine (HET0016), a Selective Inhibitor of 20-HETE Synthesis(Pharmacology)
- Suppression of AGE Precursor Formation Following Unilateral Ureteral Obstruction in Mouse Kidneys by Transgenic Expression of α-Dicarbonyl/L-Xylulose Reductase